Padma-Nathan Harin 4
4 · NURX PHARMACEUTICALS, INC. · Filed Nov 4, 2009
Insider Transaction Report
Form 4
Padma-Nathan Harin
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2009-10-13$0.25/sh+200,000$50,000→ 799,999 total - Purchase
Common Stock Warrants (right to buy)
2009-09-23+153,000→ 153,000 totalExercise: $4.00From: 2009-09-25Exp: 2013-05-16→ Common Stock (153,000 underlying) - Purchase
Common Stock
2009-09-23+99,999→ 599,999 total
Holdings
- 125,000(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]The reporting person acquired 99,999 shares and warrants to acquire 153,000 shares for an aggregate purchase price of $20,000.